SAGE Therapeutics is a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-threatening, rare CNS disorders. SAGE's lead program, SAGE-547, is in clinical development for super-refractory status epilepticus and is the first of several compounds the company is developing in its portfolio of potential seizure medicines. SAGE's proprietary chemistry platform has generated multiple new compounds that target GABA A and NMDA receptors, which are broadly accepted as impacting many psychiatric and neurological disorders.
SAGE Therapeutics is a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-threatening, rare CNS disorders. SAGE's lead program, SAGE-547, is in clinical development for super-refractory status epilepticus and is the first of several compounds the company is developing in its portfolio of potential seizure medicines. SAGE's proprietary chemistry platform has generated multiple new compounds that target GABA A and NMDA receptors, which are broadly accepted as impacting many psychiatric and neurological disorders.
Recent Articles
- Class Action Investigation for Nike NFT Investors by Rosen Law Firm
- Investors Encouraged to Join Ibotta Securities Class Action
- Comstock Resources Announces Positive First Quarter 2025 Results
- BKV Corp. and Comstock Resources Unite for Carbon Capture Efforts
- Insights from Trupanion's 2024 Annual Shareholder Letter
- Davis Commodities Reports 2024 Fiscal Year Financial Outcomes
- Allied Properties Reports Strong First Quarter Results
- Markel Group's Q1 2025 Financial Performance Examined
- Leaders Unite to Shape the Future of Higher Education
- Exciting New Chapter: Grand Opening of Dave's Hot Chicken
- Jacobs Declares Special Dividend Amid Strategic Spin-Off Developments
- Corteva's Dividend Announcement: A Positive Step for Shareholders
- Ellomay Capital's Annual Report Highlights Sustainable Growth
- Understanding Wellchange Holdings' Nasdaq Notification and Future Plans
- Leadership Changes at MS Transverse Enhance Strategic Vision
- NovoEd Achieves Diamond-Level Certification from Brandon Hall Group
- Exploring CaskX's Innovative American Single Malt Whiskey
- Transformative $50 Million Initiative for Amazon Conservation
- Join the XenDex Presale: Last Chance to Invest in $XDX
- Maxeon Solar Technologies Reports Financial Results for 2024
- WSP Global's Commitment to Sustainability: A Clear Path Forward
- Oak Woods Acquisition Corporation Faces Nasdaq Compliance Challenges
- Microvast Prepares for First Quarter Earnings Webcast Event
- Colabor Group to Host Virtual Annual Shareholders’ Meeting
- Everland and BNP Paribas Empower Indigenous Forest Conservation
- Castle Biosciences Leads Melanoma Testing with DecisionDx
- Enhancing Nurse Safety and Well-Being Through Legislation
- Florida Plastic Surgery & MedSpa Celebrates Community Awards
- Expert Guidance for Families Facing Rising Dementia Cases
- Spin Master Achieves Notable Growth in Q1 2025 Performance
- SHARC Energy Reports Strong Growth in 2024 Financial Performance
- Ultragenyx Pharmaceutical's Upcoming Financial Call Overview
- NVIDIA Announces Conference Call for Q1 Financial Results
- First of Long Island Corporation Posts Solid Q1 2025 Earnings
- Parks! America, Inc. Implements Strategic Stock Split Actions
- Methanex Achieves Strong Q1 Results with Increased Sales and EBITDA
- Exco Technologies Reports Strong Q2 Performance Amid Challenges
- Ashland Adjusts Fiscal Outlook Amid Mixed Demand Conditions
- Element Fleet Management Reports Robust Q1 2025 Performance
- Atlas One Capital Corporation Announces 2024 Financial Results
- AGF Investments Reduces Fees and Adjusts Risk Ratings
- Ball Corporation Board Approves Upcoming Quarterly Dividend
- Southwest Gas Holdings Announces Solid Dividend for Shareholders
- DallasNews Corporation Reports Strong Q1 Results with Growth
- Wyndham Hotels & Resorts Achieves Record Growth in Q1 2025
- Solomon Ponniah Welcomed as New Group Leader at Dime
- Unitil Corporation Announces New Board Members and Future Plans
- ATN International, Inc. Releases Financial Results for Q1 2025
- Summit Hotel Properties Shows Growth Amid Economic Challenges
- OneStream's Upcoming Investor Conference Participation Update